Identifying High-Attenuating and Low-Attenuating Muscle Using Computerized Tomography and Exploring Its Impact on...

Area of Science:

• Radiology
• Medical Imaging
• Sarcopenia Research

Background:

• Computed tomography (CT) methods for sarcopenia in obesity lack differentiation between muscle types.
• Existing CT techniques do not distinguish high-attenuating from low-attenuating muscle.
• Accurate muscle assessment in obese patients is crucial for understanding sarcopenia.

Purpose of the Study:

• To determine agreement between a novel CT method and commercial software for psoas muscle cross-sectional area (CSA) in obese patients.
• To explore the relationship between high-attenuating muscle quantity and physical functioning in obese medical intensive care unit (MICU) patients.
• To validate a CT-based approach for sarcopenia assessment in obesity.

Main Methods:

• Prospective observational cross-sectional study involving obese MICU patients.
• Reconstruction of CT images to calculate total, low-attenuating, and high-attenuating psoas muscle CSA using a CT method and commercial software.
• Blinded outcome measures of CSA, physical function, and muscle strength in 28 patients.

Main Results:

• Strong agreement (concordance correlation coefficient = 0.96) between the CT method and commercial software for total psoas muscle CSA.
• Moderate correlation found between high-attenuating psoas muscle CSA and modified Medical Research Council muscle strength scores (r = 0.47, P = 0.01).
• Moderate correlation also observed between high-attenuating psoas muscle CSA and lower extremity strength (r = 0.40, P = 0.04).

Conclusions:

• The developed CT method shows strong agreement with commercial software for total psoas muscle CSA in obese individuals.
• Increased high-attenuating psoas muscle CSA is moderately associated with improved muscle strength.
• Further research with objective strength markers is recommended to validate these findings.